<DOC>
	<DOCNO>NCT02532036</DOCNO>
	<brief_summary>TB040 clinical trial investigate compare effect candidate Tuberculosis ( TB ) vaccine , MVA85A , administer aerosol inhale route intramuscular route healthy adult volunteer latently infect Mycobacterium tuberculosis .</brief_summary>
	<brief_title>MVA85A Aerosol v Intramuscular Vaccination Adults With Latent Mycobacterium Tuberculosis ( M. tb ) Infection</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<criteria>Volunteers must meet follow criterion enter trial : Healthy adult age 1855 year Resident near Oxford , Birmingham London duration trial period Screening IGRA positive Ineligible chemoprophylaxis latent M.tb infection , decline prophylaxis consider low risk due distant contact history Chest Computed Tomography ( CT ) normal ; abnormal feature consistent primary M.tb infection feature suggestive active disease No relevant finding medical history physical examination Allow Investigators discuss individual 's medical history General Practitioner Use effective contraception duration trial period ( female ) Refrain blood donation trial Give write informed consent Allow Investigator register volunteer detail confidential database ( The Overvolunteering Protection Service ) prevent concurrent entry clinical trial Able willing ( Investigator 's opinion ) comply trial requirement Volunteers must meet none follow criterion enter trial : Participation another research study involve receipt investigational product 30 day precede enrolment , plan use trial period Prior vaccination candidate vaccine MVA85A , candidate vaccine FP85A , recombinant MVA vaccine candidate TB vaccine Administration immunoglobulins and/or blood product within three month precede plan trial vaccination date Clinically significant history skin disorder , allergy , atopy , immunodeficiency ( include HIV ) , cancer ( except BCC CIS ) , cardiovascular disease , gastrointestinal disease , liver disease , renal disease , endocrine disorder , neurological illness , psychiatric disorder , drug alcohol abuse Concurrent oral systemic steroid medication concurrent use immunosuppressive agent History anaphylaxis vaccination allergy likely exacerbate component trial vaccine , sedative drug , local general anaesthetic agent Pregnancy , lactation intention become pregnant trial period Any respiratory disease , include asthma Current smoker Clinically significant abnormality screen CT thorax Clinically significant abnormality pulmonary function test Any nasal , pharyngeal , laryngeal find precludes bronchoscopy Current use medication take nasal inhaled route include cocaine recreational drug Clinical , radiological , laboratory evidence current active TB disease Past treatment TB disease Any clinically significant abnormality screen blood urine test Positive HBsAg , HCV HIV antibodies Any significant disease , disorder , finding , , opinion Investigator , may either put volunteer risk , affect volunteer 's ability participate trial impair interpretation trial data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>MVA85A</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Aerosol</keyword>
</DOC>